Cibeqsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-12-30
Share capital
5,000.00 PLN
Registered address
ul. Stefana Jaracza 6/4, 00-378 Warszawa, Poland

Financials

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2024, 63 days late).

  • 2025not filed
  • 202416/09/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Wholesale of pharmaceutical goods1,210 / 1,550
Top 78%
Division · Wholesale trade22,253 / 28,996
Top 77%
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles32,574 / 42,241
Top 77%
Voivodeship · Mazowieckie89,523 / 142,033
Top 63%
Country · Poland322,156 / 495,860
Top 65%

Results vs industry

Revenue
This companyUSD 59.14kMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD -15.16kMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 73.51kMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 13.21kMedianUSD 609.81kAverageUSD 11.84m

Industry

Authorized Representatives

Maciej Andrzej Karbowiak – Management Board Member
Cyprian Konstanty Kostewicz – President of the Management Board

Manner of representation

In the case of a multi-member management board, the company is represented by two members of the management board acting jointly, or by one member of the management board acting with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Maciej Andrzej Karbowiakage 57
49$661.8049%
Cyprian Konstanty Kostewiczage 55
49$661.8049%
Others
2$27.012%

Bank accounts

Registered as a VAT taxpayer on 2018-04-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $1,180.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$292
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$444
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$444

Competitors

Name
Vorwarts Pharmasp. z o.o.
Black & Whitesp. z o.o.
Osteoprofsp. z o.o.
THC PharmaS.A.
EDGE Pharmasp. z o.o.
Arcade Internationalsp. z o.o.
Filicosp. z o.o.
Get Ready Wheelchairssp. z o.o.
Jacek Waksmundzki Trust 2S.K.A.
Optimedussp. z o.o.

FAQ

Last updated: 2026-04-16